| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |